Clinical Trial Update: Acamprosate in Youth With Fragile X Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial of acamprosate in youth with Fragile X Syndrome and autism spectrum disorders has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorders
• Fragile Syndrome

Drugs mentioned

• acamprosate (acamprosate)

Snippet

Sponsor: Indiana University | Conditions: Fragile X Syndrome, Autism Spectrum Disorders | Phase 2 | Status: COMPLETED | Results posted: 2017-04-28